title: Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients.
abstract: Our group has shown in a randomized clinical trial that psychological intervention to reduce stress in patients with stages II and III breast cancer led to enhanced immune function, fewer recurrences and improved overall survival. We hypothesized that patients with high levels of stress would have alterations in myeloid-derived suppressor cells (MDSC) compared to patients with lower stress. PBMC from 16 patients with high stress (n = 8) or with low stress (n = 8) after surgery as measured by the Impact of Event Scale (IES) questionnaire were evaluated for the presence of MDSC. Patients with higher IES scores had significantly elevated salivary cortisol levels (P = 0.013; 13 μg/dl vs. 9.74 μg/dl). Levels of IL-1Rα were also significantly elevated in the higher IES group (45.09 pg/ml vs. 97.16 pg/ml; P = 0.010). IP 10, G-CSF, and IL-6 were all higher in the high stress group although not to a significant degree. Flow cytometric analysis for CD33+/HLA-DR-neg/CD15+/CD11b+ MDSC revealed increased MDSC in patients with lower IES scores (P = 0.009). CD11b+/CD15+ cells constituted 9.4% of the CD33+/HLA DR-neg cell population in patients with high IES, vs. 27.3% in patients with low IES scores. Additional analyzes of the number of stressful events that affected the patients in addition to their cancer diagnosis revealed that this type of stress measure correlated with elevated levels of MDSC (P = 0.064). These data indicate the existence of a complex relationship between stress and immune function in breast cancer patients.
authors: Department of Integrated Biomedical Sciences, The Ohio State University, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH 43210, USA.
authors: Bethany L
authors: BL
authors: Mundy-Bosse
authors: Lisa M
authors: LM
authors: Thornton
authors: Hae-Chung
authors: HC
authors: Yang
authors: Barbara L
authors: BL
authors: Andersen
authors: William E
authors: WE
authors: Carson
references: Cancer Res. 2007 Oct 15;67(20):10019-26
references: 17942936
references: Nat Rev Cancer. 2006 Mar;6(3):240-8
references: 16498446
references: Nat Rev Immunol. 2009 Mar;9(3):162-74
references: 19197294
references: Cancer. 2005 Jul 15;104(2):305-13
references: 15954082
references: Health Psychol. 2002 Nov;21(6):531-41
references: 12433005
references: Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9090-5
references: 12840146
references: Lancet. 1995 Jan 14;345(8942):99-103
references: 7815892
references: J Immunol. 2009 Apr 15;182(8):4499-506
references: 19342621
references: Am J Psychiatry. 2004 Aug;161(8):1397-403
references: 15285965
references: Clin Immunol Immunopathol. 1997 May;83(2):190-4
references: 9143381
references: Psychoneuroendocrinology. 1995;20(3):269-80
references: 7777655
references: Psychol Bull. 2004 Jul;130(4):601-30
references: 15250815
references: Am Psychol. 1997 Feb;52(2):101-16
references: 9104085
references: J Immunol. 2006 Jan 1;176(1):284-90
references: 16365420
references: Acta Psychiatr Scand. 2001 Mar;103(3):226-8
references: 11240580
references: J Cell Mol Med. 2009 Sep;13(9B):3939-50
references: 20196788
references: J Immunol. 2002 Jan 15;168(2):689-95
references: 11777962
references: Cancer Res. 2008 Apr 15;68(8):2561-3
references: 18413722
references: Nat Biotechnol. 2007 Aug;25(8):911-20
references: 17664940
references: J Exp Med. 2008 Sep 29;205(10):2235-49
references: 18809714
references: J Natl Cancer Inst. 1998 Jan 7;90(1):30-6
references: 9428780
references: Cancer Immunol Immunother. 2008 Oct;57(10):1471-81
references: 18327581
references: J Surg Res. 2007 May 1;139(1):36-44
references: 17292412
references: Int Immunopharmacol. 2009 Jul;9(7-8):900-9
references: 19336265
references: J Exp Med. 1995 Jan 1;181(1):435-40
references: 7807024
references: Anesth Analg. 1996 Mar;82(3):492-7
references: 8623949
references: Clin Cancer Res. 2009 Mar 15;15(6):2148-57
references: 19276286
references: Ann Surg Oncol. 2008 Jul;15(7):2042-52
references: 18398660
references: J Clin Invest. 2008 Dec;118(12):4036-48
references: 19033672
references: J Immunol. 2009 May 1;182(9):5693-701
references: 19380816
references: Psychosom Med. 1979 May;41(3):209-18
references: 472086
references: PLoS One. 2009;4(1):e3590
references: 19177163
references: J Immunol. 1998 Nov 15;161(10):5313-20
references: 9820504
references: J Clin Invest. 2006 Oct;116(10):2777-90
references: 17016559
references: J Immunol. 2004 Jan 15;172(2):989-99
references: 14707072
references: Blood. 2000 Dec 1;96(12):3838-46
references: 11090068
references: J Immunol. 1999 May 15;162(10):5728-37
references: 10229805
references: J Clin Oncol. 2004 Sep 1;22(17):3570-80
references: 15337807
references: Psychosom Med. 1993 Jul-Aug;55(4):364-79
references: 8416086
references: Cancer Res. 2007 Jan 1;67(1):425; author reply 426
references: 17210725
references: J Immunol. 2009 Jan 1;182(1):240-9
references: 19109155
references: Eur J Immunol. 2009 Oct;39(10):2670-2
references: 19757440
references: Cancer. 2008 Dec 15;113(12):3450-8
references: 19016270